Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Van Boxtel

Thoracic Surgery (Cardiothoracic Vascular Surgery) Morristown, NJ Medical Doctor

NPI 1962727644 CMS profile 7215283

Mid-Atlantic Surgical Associates, 100 Madison Avenue, Morristown, NJ 07960

Open in the dashboard

General payments

$39,867

411 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Van Boxtel of Morristown, NJ is reported in the CMS Open Payments database as having received $39,867 across 411 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,488 109
2024 General $15,895 109
2023 General $2,454 72
2022 General $1,834 41
2021 General $1,270 35
2020 General $488 15
2019 General $2,437 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Van Boxtel
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Benjamin Van Boxtel were reported at $15,488. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Benjamin Van Boxtel Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $2,437 $886 $178–$3,167 $163
2020 $488 $341 $108–$1,605 $114
2021 $1,270 $453 $125–$1,886 $132
2022 $1,834 $695 $180–$2,566 $149
2023 $2,454 $745 $205–$2,662 $160
2024 $15,895 $799 $214–$2,967 $164
2025 $15,488 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $26,103 54 payments
  2. Edwards Lifesciences Corporation $4,998 165 payments
  3. CryoLife, Inc. $2,090 15 payments
  4. Bolton Medical Inc $2,002 22 payments
  5. Medtronic, Inc. $1,606 82 payments
  6. Abbott Laboratories $1,294 19 payments
  7. Atricure, Inc. $851 22 payments
  8. Medtronic Vascular, Inc. $168 7 payments
  9. Baxter Healthcare $138 6 payments
  10. Janssen Pharmaceuticals, Inc $123 1 payment
  11. Other $495 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $22,813 23 payments
  2. Food and Beverage $11,627 365 payments
  3. Travel and Lodging $5,130 21 payments
  4. Long term medical supply or device loan $282 1 payment
  5. Entertainment $16 1 payment
Products named General payments · program years 2019–2025
  1. A&E MEDICAL / STERNALOCK XP RIGID FIXATION SYSTEM $9,455 17 payments
  2. A&E Medical / Thorecon Disposable Plate Cutter $7,079 4 payments
  3. SAPIEN 3 Ultra RESILIA $2,661 111 payments
  4. RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM $1,561 5 payments
  5. Cardiac non-SynerGraft $1,515 8 payments
  6. COREVALVE EVOLUT R $989 67 payments
  7. HeartMate 3 Left Ventricular Dev $682 8 payments
  8. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $616 19 payments
  9. BioGlue $539 5 payments
  10. On-X $539 5 payments
  11. Other $5,689 137 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

34

Median for Cardiac Surgery: 68

Drug cost

$212

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 34 $212

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$274,350

Medicare's payments for the services billed

Medicare patients

202

Average age 78

Services billed

420

80 women, 122 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Chronic kidney disease 69%
Arthritis 53%
Atrial fibrillation 42%
Diabetes 39%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

411 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record